Chen Xuliang, Zhu Hengkai, Tao Liyan, Zheng Shusen, Guo Hua
Department of Hepatobiliary and Pancreatic Surgery, Key Laboratory of Artificial Organs and Computational Medicine in Zhejiang Province, Shulan (Hangzhou) Hospital, Shulan International Medical College Zhejiang Shuren University Hangzhou P. R. China.
Clin Case Rep. 2025 Aug 13;13(8):e70652. doi: 10.1002/ccr3.70652. eCollection 2025 Aug.
This report presents a rare case of a 43-year-old man with unresectable combined hepatocellular-cholangiocarcinoma who, after undergoing transarterial chemoembolization, systemic chemotherapy, and stereotactic body radiation therapy, accepted curative resection and obtained an overall survival of 25 months to date. The case highlights the need for adaptable treatment regimens due to the tumor's components and underscores the importance of surgery for long-term success.
本报告介绍了一例罕见病例,一名43岁男性患有不可切除的肝细胞胆管癌,在接受经动脉化疗栓塞、全身化疗和立体定向体部放射治疗后,接受了根治性切除,迄今为止总生存期为25个月。该病例凸显了由于肿瘤成分而需要采用适应性治疗方案的必要性,并强调了手术对于长期成功的重要性。